Cannabinoid CB
Journal
British journal of pharmacology
ISSN: 1476-5381
Titre abrégé: Br J Pharmacol
Pays: England
ID NLM: 7502536
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
received:
29
08
2018
revised:
11
12
2018
accepted:
30
01
2019
pubmed:
16
2
2019
medline:
16
7
2020
entrez:
16
2
2019
Statut:
ppublish
Résumé
Endocannabinoids are critically involved in brain reward functions, mediated by activation of CB In the present study, we used the electrical intracranial self-stimulation paradigm to evaluate the effects of various cannabinoid drugs on brain reward in laboratory rats and the roles of CB Two mixed CB CB
Sections du résumé
BACKGROUND AND PURPOSE
Endocannabinoids are critically involved in brain reward functions, mediated by activation of CB
EXPERIMENTAL APPROACH
In the present study, we used the electrical intracranial self-stimulation paradigm to evaluate the effects of various cannabinoid drugs on brain reward in laboratory rats and the roles of CB
KEY RESULTS
Two mixed CB
CONCLUSIONS AND IMPLICATIONS
CB
Identifiants
pubmed: 30767215
doi: 10.1111/bph.14625
pmc: PMC6468271
doi:
Substances chimiques
Cannabinoids
0
Receptor, Cannabinoid, CB1
0
Receptor, Cannabinoid, CB2
0
Types de publication
Journal Article
Research Support, N.I.H., Intramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1268-1281Informations de copyright
© 2019 The British Pharmacological Society.
Références
Neuron. 2016 Sep 21;91(6):1244-1252
pubmed: 27618677
Proc Natl Acad Sci U S A. 2014 Nov 18;111(46):E5007-15
pubmed: 25368177
Nature. 1993 Sep 2;365(6441):61-5
pubmed: 7689702
Genes Brain Behav. 2009 Jul;8(5):519-30
pubmed: 19496827
Br J Pharmacol. 2010 Aug;160(7):1577-9
pubmed: 20649561
Int J Neuropsychopharmacol. 2017 Mar 1;20(3):269-278
pubmed: 27994006
Sci Rep. 2017 Sep 26;7(1):12315
pubmed: 28951549
Neurosci Lett. 2006 Mar 27;396(2):113-6
pubmed: 16356641
Neuropsychopharmacology. 2010 Dec;35(13):2564-78
pubmed: 20827272
Neurosci Lett. 2016 Feb 26;615:60-5
pubmed: 26797579
J Addict Med. 2014 Mar-Apr;8(2):130-6
pubmed: 24365805
Annu Rev Neurosci. 1996;19:319-40
pubmed: 8833446
Ann N Y Acad Sci. 2008 Oct;1139:434-49
pubmed: 18991891
J Pharmacol Exp Ther. 1997 Dec;283(3):1160-7
pubmed: 9399989
Br J Pharmacol. 2004 Sep;143(2):227-34
pubmed: 15313883
Neuropsychopharmacology. 2006 Jul;31(7):1393-405
pubmed: 16205781
J Neurosci. 2006 Aug 16;26(33):8531-6
pubmed: 16914679
J Pharmacol Exp Ther. 1992 Dec;263(3):1118-26
pubmed: 1335057
J Am Chem Soc. 1971 Jan 13;93(1):217-24
pubmed: 5538858
Eur J Neurosci. 2002 Jun;15(12):2057-61
pubmed: 12099913
Curr Psychiatry Rep. 2009 Oct;11(5):353-9
pubmed: 19785975
Neurosci Lett. 1991 Aug 5;129(1):136-80
pubmed: 1656336
Pharmacol Rev. 2014 Jul;66(3):869-917
pubmed: 24973197
Behav Pharmacol. 1994 Apr;5(2):219-225
pubmed: 11224271
Science. 2005 Oct 14;310(5746):329-32
pubmed: 16224028
Nucleic Acids Res. 2018 Jan 4;46(D1):D1091-D1106
pubmed: 29149325
Addict Biol. 2017 May;22(3):752-765
pubmed: 26833913
J Pharmacol Exp Ther. 2015 Feb;352(2):195-207
pubmed: 25398241
Br J Pharmacol. 2019 May;176(9):1268-1281
pubmed: 30767215
Pharmacol Biochem Behav. 1991 Nov;40(3):587-91
pubmed: 1725460
Curr Med Chem. 2010;17(14):1360-81
pubmed: 20166927
Clin Pharmacol Ther. 1977 Jan;21(1):26-33
pubmed: 832447
Neuropsychopharmacology. 2017 Jun;42(7):1522-1530
pubmed: 28059083
Acta Pharmacol Sin. 2019 Mar;40(3):398-409
pubmed: 29967455
Cell Rep. 2017 Jul 11;20(2):319-332
pubmed: 28700935
Neuropharmacology. 2005 Jun;48(8):1105-16
pubmed: 15878779
Nat Neurosci. 2011 Jul 24;14(9):1160-6
pubmed: 21785434
J Pharmacol Exp Ther. 2012 Nov;343(2):389-400
pubmed: 22892341
Sci Rep. 2017 Dec 12;7(1):17410
pubmed: 29234141
Neuropharmacology. 2009 Jul;57(1):60-6
pubmed: 19393252
J Oral Surg. 1976 Apr;34(4):301-13
pubmed: 1062533
Neuropsychopharmacology. 2004 Aug;29(8):1558-72
pubmed: 15173844
Int J Neuropsychopharmacol. 2013 Nov;16(10):2273-84
pubmed: 23830148
Behav Pharmacol. 2007 Jul;18(4):311-9
pubmed: 17551324
Psychopharmacology (Berl). 1988;96(1):142-4
pubmed: 2852376
Synapse. 2008 Dec;62(12):944-9
pubmed: 18798269
Neuropsychopharmacology. 2015 Mar;40(4):1037-51
pubmed: 25374096
Neuron. 2016 May 18;90(4):795-809
pubmed: 27133464
Nat Rev Neurosci. 2015 Oct;16(10):579-94
pubmed: 26373473
Psychopharmacology (Berl). 2014 Jun;231(12):2461-70
pubmed: 24408209
Psychopharmacology (Berl). 2008 Mar;196(4):533-42
pubmed: 17985117
Neuropsychopharmacology. 2012 Jun;37(7):1749-63
pubmed: 22414816
Psychopharmacology (Berl). 2006 Oct;188(3):293-305
pubmed: 16953388
Handb Exp Pharmacol. 2005;(168):299-325
pubmed: 16596779
Psychopharmacology (Berl). 2005 May;179(2):498-508
pubmed: 15821959
Life Sci. 1996;58(25):PL365-72
pubmed: 8649214
Int J Neuropsychopharmacol. 2006 Oct;9(5):585-602
pubmed: 16942635
Neuroscience. 2012 Dec 27;227:313-26
pubmed: 23069763
Nat Neurosci. 2000 Nov;3(11):1073-4
pubmed: 11036260
Br J Pharmacol. 2017 Dec;174 Suppl 1:S17-S129
pubmed: 29055040
Curr Top Behav Neurosci. 2017;32:249-262
pubmed: 28012093
Mol Pain. 2014 Apr 18;10:27
pubmed: 24742127
Ann N Y Acad Sci. 2006 Aug;1074:514-36
pubmed: 17105950
Curr Drug Abuse Rev. 2008 Nov;1(3):350-74
pubmed: 19630731
Proc Natl Acad Sci U S A. 2014 Nov 25;111(47):16913-8
pubmed: 25385625
Science. 1997 Jun 27;276(5321):2048-50
pubmed: 9197269
Brain Res. 2006 Feb 3;1071(1):10-23
pubmed: 16472786
Neuropharmacology. 2007 Nov;53(6):771-82
pubmed: 17888459
Psychopharmacology (Berl). 2003 Sep;169(2):135-40
pubmed: 12827345
Curr Pharm Des. 2014;20(13):2072-88
pubmed: 23829366
Acta Otolaryngol. 2008 Sep;128(9):961-7
pubmed: 19086305
Behav Pharmacol. 2012 Dec;23(8):802-5
pubmed: 23075707
Nature. 1990 Aug 9;346(6284):561-4
pubmed: 2165569
Trends Neurosci. 2006 Apr;29(4):225-32
pubmed: 16483675
Mol Cell Endocrinol. 2008 Apr 16;286(1-2 Suppl 1):S97-S107
pubmed: 18372102
Neuropsychopharmacology. 2008 Jun;33(7):1735-45
pubmed: 17728698